Micro- and Nanotechnology Empowering Combination Therapy of Cancer and Chronic Diseases
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 45
Special Issue Editor
Interests: nanotechnology; drug delivery; computer-aided design; nanomedicine; hydrogel; long-acting injectable; controlled drug release; combination therapy; bioavailability; biological barrier
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Combination therapy has shown significance in clinical practice for cancer and many chronic diseases due to its promise in outpacing the efficiency of any singular treatment method. The novel approach strategically amalgamates various treatment modalities, including but not limited to the synergistic combination of chemo-drugs and/or molecular therapy, the combination of small-molecule drugs such as antibiotics and steroids, the integration of immunotherapy into traditional chemotherapy, theranostics, and multicomponent natural medicine extract. Drug formulation is a critical aspect of pharmaceutical development to create viable drug products of combination therapy with desired properties. An optimized design and preparation of formulation/drug delivery system can meet the growth demand for safer and more effective combination treatment.
To adeptly address the complexity of disease heterogeneity and treatment resistance, this Special Issue highlights and captures the recent progress and contemporary landscape of combination therapy in various modalities/formulations/dosage forms empowered by the advent of micro- and nanotechnologies as well as supervised artificial intelligence. We are pleased to invite you to submit all types of pertinent articles, and topics of interest include (but are not limited to) drug delivery technologies/methods, design and characterization (e.g., drug release and excipient selection), therapeutic evaluations in cancer and chronic diseases, and novel treatment regimens.
Dr. Rui Xue Zhang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanotechnology
- drug delivery
- computer-aided design
- nanomedicine
- hydrogel
- long-acting injectable
- controlled drug release
- combination therapy
- bioavailability
- biological barrier
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
